Florence raises funds to advance clinical trial connectivity
Led by Insight Partners, the financing round was joined by existing investors Fulcrum Equity Partners, Bee Partners, and Flashpoint.
News
Isofol concludes Japanese enrolment in Phase III cancer drug study
Isofol Medical has concluded the enrolment of Japanese subjects in the global Phase III AGENT...
Enanta’s EDP-514 reduces HBV viral load in Phase Ib trial
Enanta Pharmaceuticals has reported results from the first two dose cohorts of Part 2 of its Phase Ib study, which...
CytoDyn and AEIH to begin trials of leronlimab in severe Covid-19
CytoDyn and academic research organisation (ARO) Albert Einstein Israelite Hospital (AEIH) are set to commence two Phase III trials of...
Adagio starts Phase II/III trial for Covid-19 prevention
Adagio Therapeutics has treated the first subject in its Phase II/III EVADE clinical trial of a monoclonal antibody, ADG20, for...
Medidata unveils adjudication system for trial endpoints
Named Medidata Adjudicate, the new digital solution is designed to track all clinical events from start to finish. It helps gather, manage, categorise, adjudicate and submit data on clinical endpoints.…
Moderna’s Covid-19 vaccine booster doses increase antibody responses
The responses were observed against the SARS-CoV-2 virus and two variants of concern, the B.1.351 variant, which was first detected in South Africa, and the P.1 variant found in Brazil.…
Rezolute’s diabetic macular oedema therapy yields positive data
Rezolute has reported that its investigational oral plasma kallikrein inhibitor (PKI), RZ402, was found to be safe and well-tolerated in treating diabetic macular oedema (DME) patients in a Phase Ia…
AbCellera’s Covid-19 antibody enters clinical trials
AbCellera has reported that antibody LY-CoV1404, developed through its partnership with Eli Lilly, entered clinical trials in subjects with mild-to-moderate Covid-19. Lilly expanded its ongoing BLAZE-4 trials to assess LY-CoV1404…
HDT Bio and Gennova dose healthy subjects in Covid-19 trial in India
HDT Bio and its development partner in India, Gennova Biopharmaceuticals, have started dosing healthy subjects with the Covid-19 vaccine in a Phase I/II trial in the country. Utilising a Lipid…
Novavax includes paediatric subjects in Covid-19 vaccine trial
Novavax has expanded the ongoing Phase III PREVENT-19 clinical trial of its recombinant protein Covid-19 vaccine candidate, NVX-CoV2373, to include a paediatric arm. NVX-CoV2373 is made from the genetic sequence…
